Screener
Ultragenyx Pharmaceutical RARE Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on trailing twelve months.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's net margin?
- Ultragenyx Pharmaceutical (RARE) reported net margin of -81.7% in Q2 2026.
- How has Ultragenyx Pharmaceutical's net margin changed year-over-year?
- Ultragenyx Pharmaceutical's net margin increased by 6.4% year-over-year, from -87.3% to -81.7%.
- What is the long-term trend for Ultragenyx Pharmaceutical's net margin?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's net margin has grown at a 4.4% compound annual growth rate (CAGR), from -68.8% to -85.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Ultragenyx Pharmaceutical's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude